HSCS (Heart Test Laboratories Inc.) Market Value to Book Value Ratio

HeartSciences (HSCS) - corporate logo

Heart Test Laboratories relies on outsourced production and cloud services, which contrasts with high management stability and investor confidence. This price-to-book multiple chart resolves this contradiction, where -6.10 records a new level. Unique patents for AI heart diagnostics ensure the business's fundamental stability, creating a significant barrier to entry for other players.

HSCS - Heart Test Labs Market-to-Book Ratio over the range 04/28/2023 - 10/27/2026

Financial and market metric breakdowns for Heart Test Laboratories, Inc. (HSCS)

- price and consensus price forecast:
Price Chart Heart Test Laboratories|HSCS - Analyst Median Target
- market capitalization data:
Market Value Heart Test Laboratories Inc.|HSCS - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share HeartSciences|HSCS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio heartsciences.com|HSCS - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Heart Test Laboratories|HSCS - Long-Term Debt to Capital|Short-Term Debt to Equity Heart Test Laboratories Inc.|HSCS - Company Aggregate Debt|Debts to Book Capitalization Heart Test Laboratories Inc.
Initial company analysis:Heart Test Laboratories - HSCS
Flagship merchandise of Heart Test Laboratories Inc.

The market capitalization to book value ratio measures the market premium over a company's net assets. A low ratio guarantees a fundamental margin of safety for the investor and minimizes the risk of deep drawdowns. By analyzing this price-to-book multiplier chart, one can assess the current business value relative to its equity. For Heart Test Laboratories (HSCS), this metric reflects the market valuation of its unique AI diagnostic algorithm patents. High technological barriers to entry justify a certain premium over the asset value.

Direct competitors

Agilent Technologies - Market Value to Book Value Ratio|DGX (questdiagnostics.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio ILMN|Market Cap to Net Assets Ratio Exact Sciences Corp|PerkinElmer - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bio-Rad Corp (BIO)|NNNN - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio soterahealth.com SHC|QuidelOrtho Corporation - Market Capitalization to Book Value Ratio|OPK: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio CareDx|Maravai (MRVI) - Capitalization to Book Value Ratio|FLGT (Fulgent Genetics, Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LAB|Market Value to Book Value Ratio Cytek Biosciences (CTKB)|Market Value to Book Value Ratio OraSure Technologies, Inc. OSUR|XGN: Market Cap to Net Assets Ratio|MDxHealth, Inc. - Market-to-Book Ratio|Market Value to Book Value Ratio LUCD (Lucid Diagnostics Inc.)|PRE - Market Capitalization to Book Value|imdxinc.com - Market Capitalization to Book Value Ratio|TRIB (Trinity Biotech) - Market Capitalization to Book Value|PRPH: Market Value to Book Value Ratio|Market Capitalization to Book Value Ainos Corporation|Co-Diagnostics, Inc. (CODX) - Market Capitalization to Book Value Ratio|Market Value to Book Value biomerica.com (BMRA)|CDIO: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Virax Biolabs Group Limited VRAX|Bluejay - Market Capitalization to Book Value Ratio|AWH: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Accelerate Diagnostics AXDX|Market Value to Book Value CENTOGENE|Enzo Biochem Inc. (ENZ) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Fresh2 (FRES)|Genetic Technologies (GENE) - Market Cap to Net Assets Ratio|Market Value to Book Value 23andMe Inc ME|Market Cap to Net Assets Ratio Psychemedics (PMD)